NSC |
Compound |
Enrichment |
Correlation |
NSC 666124 |
Null |
0.0237269271456697 |
0.3825172 |
NSC 669517 |
Null |
0.0237269271456697 |
0.10160278 |
NSC 677369 |
Null |
0.0237269271456697 |
0.18102597 |
NSC 687523 |
Null |
0.0237269271456697 |
0.1793048 |
NSC 696073 |
Null |
0.0237269271456697 |
0.076138383 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0237269271456697 |
0.25329821 |
NSC 732936 |
5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0237269271456697 |
0.10280155 |
NSC 735472 |
(2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol |
0.0237269271456697 |
0.19440598 |
NSC 741459 |
(11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 |
0.0237269271456697 |
-0.079486553 |
NSC 752761 |
Null |
0.0237269271456697 |
0.022803737 |